Skip to main content

Table 7 Clinical data and pathological features of the 2 feline injection site sarcomas (FISSs) used for the establishment of primary cells

From: Investigating the role of signal transducer and activator of transcription 3 in feline injection site sarcoma

  FISS-10 FISS-14 (NTU2018-1134)
Breed Mixed Mixed
Sex/Age(years) Spayed female/10y Castrated male/6y
Tumor size <5cm >5cm
Location Left scapula Left trunk
Pathological diagnosis Sarcoma Fibrosarcoma
Grading II-III II
cbIHC/daICC profile   
eSTAT3 2/+ 2/+
fPhospho-STAT3 (Tyr705) 0/- 2/+
  1. aICC criteria: - = negative; + = more than 5% cells positive
  2. bIHC criteria: count 10 HPF for each section (at least 1000 cells), 0 = negative; 1 = less than 10% cells positive; 2 = 10-50% cells positive; 3 = more than 50% cells positive
  3. cIHC immunohistochemistry
  4. dICC immunocytochemistry
  5. eSTAT3 signal transducer and activator of transcription 3
  6. fPhospho-STAT3 (Try705) = signal transducer and activator of transcription 3 phosphorylated at tyrosine 705